Plan now to have your poster included in the 2025 Cancer Research & Oncology Virtual Event. Submission is free. Submit your abstract here. Our virtual conference allows you to participate in a global ...

Vepdegestrant is being developed as a potential monotherapy and as part of combination therapy across multiple treatment settings for ER+/HER2- metastatic breast cancer. In July 2021, Arvinas ...